S9 (2024) and S10 solutions for monitoring blood oxygen levels in the USA? [COMBINED]

The former CEO of Masimo participated in multiple public interviews where he expressed a willingness to negotiate, yet Apple has responded with silence and legal action aimed at bypassing the patents.

In a statement to CNBC last year, Tim Cook remarked, “our focus is on appeals,” indicating that they do not plan to pursue licensing options.

This conflict has been ongoing since January 2020. It’s been five years. If Apple wanted to settle or could develop their own tech, they would have done so by now. Anything about Apple willing to settle or reenabling the hypothetical hardware on U.S. S10 models is wishful thinking.

With just three years remaining until the relevant patents expire, Apple is unlikely to invest heavily in Masimo. Consumers seeking a Watch that monitors blood oxygen levels can simply cross the land borders to the north or south to find one.